BioSpace News Archive

Industry professionals and community members are invited to read and attend a conversation about “Caste: The Origins of Our Discontents” by Isabel Wilkerson

Teracero Pharma Inc. (“teräcero”) and its German partner nal von Minden GmbH (“nal von Minden”) are pleased to announce that Health Canada, pursuant to the Interim order Respecting the Importation and Sale of Medical Devices in support against the COVID-19 pandemic, has issued an authorization for importation and commercialization of nal von Minden’s NADAL COVID-19 IgG/IgM Test (“NADAL Rapid Test”),

Coala Life today announced the results of the groundbreaking RedHeart Study where the Coala Heart Monitor (“Coala”) was used to evaluate 821 women with palpitation symptoms for over 60 days

Venarum Medical announced receipt of a Phase I SBIR Grant award for development of K9-ICT: A Novel Urethral Valve Treatment for Canine Urinary Incontinence.

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that management will participate in the Investor Summit Group’s Q1 Virtual Summit, which is being held from March 23th-25th.

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced the appointments of Leslie Trigg and Katey Owen, Ph.D. to its Board of Directors effective immediately.

ContraFect Corporation, a clinical-stage biotechnology company focused on discovering and developing direct lytic agents for the treatment of life-threatening infectious diseases, announced that it has commenced an underwritten public offering of shares of its common stock.

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced that, following a vote in favor of the transaction by the Armata shareholders,

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that Gary Maharaj, president and chief executive officer, and Tim Arens, senior vice president of finance and chief financial officer, will make a presentation at the Sidoti & Company Virtual Investor Conference

CTI BioPharma Corp. (Nasdaq: CTIC) today reported its financial results for the fourth quarter and full year ended December 31, 2020.